Norges Bank’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Norges Bank’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-17,500	Closed	-$425K	–	2150
2017 Q3	$425K	Hold	17,500	–	–	﹤0.01%	2102
2017 Q2	$390K	Buy	+17,500	New	+$368K	﹤0.01%	2094

Other funds holding DOVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

Norges Bank's DOVA Position: Q4 2017 in Review

Norges Bank sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2017, closing a stake of 17,500 shares — an estimated $425K sold.

Norges Bank first reported a position in DOVA in Q2 2017 and held it in 2 quarters. The position peaked at $425K in Q3 2017. 48 funds tracked by Wall St. Rank hold DOVA as of Q4 2017.

Norges Bank reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Norges Bank sold 17,500 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2017, an estimated $425K.
Norges Bank first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2017 and held it in 2 quarters.
Norges Bank's Dova Pharmaceuticals, Inc. Common Stock position peaked at $425K in Q3 2017.
48 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2017.

Based on Norges Bank's 13F filing for Q4 2017, filed 9 Feb 2018.